Cite

HARVARD Citation

    Huang, X. et al. (n.d.). Safety and Efficacy of Lenvatinib Plus Nivolumab in Unresectable Hepatocellular Carcinoma: A Retrospective Study in China. HPB. pp. S124-S125. [Online]. 
  
Back to record